Has Anita Wasan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,302 in general payments to Anita Wasan, MD across 455 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anita Wasan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anita Wasan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anita Wasan, MD

Allergy & Immunology · Lansdowne, VANPI 1093897597

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 20.2%. 2025 is the largest year on record at $8,645, more than ten times the $645 reported in 2019.

$17,302in general payments, 2019–2025

Across 455 payments — averaging $38.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$3K
Arcutis Biotherapeutics, Inc.$3K
ARS Pharmaceuticals Operations, Inc.$2K
AstraZeneca$2K
GSK$1K
Optinose US, Inc.$1K
plus $4K from 26 others

What the payments were for

Consulting fees$3,98023%
Speaking & faculty fees$3,98423%
Food & beverage$9,31154%
Education$270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	44	$3,493
Arcutis Biotherapeutics, Inc.	3	$3,286
ARS Pharmaceuticals Operations, Inc.	7	$2,381
AstraZeneca	96	$1,822
GSK	53	$1,078
Optinose US, Inc.	60	$1,036
Regeneron Healthcare Solutions, Inc.	32	$893
Pfizer	22	$506
Kaleo, Inc.	20	$405
Incyte Corporation	16	$325
Alk-abello, Inc	9	$319
Teva Pharmaceuticals USA, Inc.	21	$283
Genentech USA, Inc.	12	$248
Amgen	7	$138
Novartis	6	$131
Lilly USA, LLC	5	$122
Aimmune Therapeutics, Inc.	6	$118
Hikma Pharmaceuticals USA	6	$92
Takeda Pharmaceuticals U.S.A., Inc.	4	$92
Boehringer Ingelheim	4	$84
Organon	3	$65
AbbVie	3	$65
Biocryst US Sales Co., LLC	3	$62
LEO Pharma Inc.	2	$53
Eyevance Pharmaceuticals LLC	2	$38
Phadia US Inc.	2	$33
Aytu Biopharma, Inc.	2	$29
CSL Behring	1	$26
Viatris Specialty LLC	1	$23
USWM, LLC	1	$22
Galderma Laboratories, L.p.	1	$19
Phathom Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$2,583
NEFFY$2,250
CIBINQO$103

How this compares

$17,302 in reported general payments places this provider in the 80th percentile of 133 allergy & immunology providers in Virginia.

See all allergy & immunology providers in Virginia →

Medicare billing

Part B allowed, 2024

$17,149

Medicare patients

Services billed

1,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	15	$395
Omeprazole	12	$88

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Lansdowne

Shaz SiddiqiLansdowne$19K
Gulbu UzelLansdowne$8K
Charles LaneLynchburg$1.4M
Jacqueline Eghrari-SabetVienna$1M
Eric KarlinWilliamsburg$522K
Nicholas RiderRoanoke$227K
Courtney BlairMc Lean$139K
Andrew KimFredericksburg$104K
Behnam DaghighLeesburg$99K
Ananth ThyagarajanBurke$97K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →